About the Manufacturer
Merck
 The filing of Fosamax lawsuits is but the latest legal blow to strike the second largest drug manufacturer in the United States. The pharmaceutical giant already faces significant legal woes in relation to another one of its drugs; Vioxx. An estimated 11,500 Vioxx lawsuits blamed the use of Merck's arthritis drug for causing patient heart attack.
Vioxx and Fosamax are two of Merck's best selling drugs. In 2005, Fosamax sales totaled more than $3 Billion. In 2003, the last full year that Vioxx was marketed, it generated more than $2.5 Billion. Many believe that the Vioxx controversy could potentially lead to the initial downfall of one of the world's largest and most successful drug manufacturers. The onset of Fosamax litigation could leave Merck & Co. mired in an inescapable legal minefield that may culminate with the company filing for bankruptcy protection.
|
 |
|
Do You Have A Potential Fosamax Case?
Contact Us Today! |
 |
Fosamax
Current News
Jaw disease may be linked to osteoporosis drugs
Bone specialists this month convened a task force to investigate a rare but troubling side effect apparently associated with widely used osteoporosis medications: jaw bone that won't heal once it is exposed. Almost 95 percent of the known cases have occurred among cancer patients taking the drugs ...read more
Another Merck Drug Is Under Legal Attack
As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the first of what could be another wave of lawsuits involving Fosamax, its second-biggest seller. The emerging litigation targeting the osteoporosis drug ...read more
|
|
|
